Skip to main content
Premium Trial:

Request an Annual Quote

R Scott Greer, Amir Nashat

Premium
R Scott Greer has been appointed to the board of medical device maker Inogen.
 
Greer, who is managing director of venture capital firm Numenor Ventures, was previously chairman of Sirna Therapeutics, which was acquired by Merck earlier this year.
 

 
Polaris Venture Partners, a venture capital firm, has named Amir Nashat as a general partner focusing on seed, early-stage, and growth equity life science companies.
 
Among Polaris’ investments is Alnylam Pharmaceuticals.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.